Isolation and identification of urinary metabolites of berberine in rats and humans

Drug Metabolism and Disposition

Volumn 36, Issue 11, 2008, Pages 2159-2165

  Qiu, Feng ^a   Zhu, Zhiyong ^a   Kang, Ning ^a   Piao, Shujuan ^a   Qin, Gengyao ^a   Yao, Xinsheng ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3,10 NORPALMATINE 10 O SULFATE; BERBERINE; BERBERRUBINE 9 O BETA DEXTRO GLUCURONIDE; COLUMBAMIN 2 O BETA DEXTRO GLUCURONIDE; DEMETHYLENEBERBERINE 2 O SULFATE; DEMETHYLENEBERBERINE 2,3 DI O BETA DEXTRO GLUCURONIDE; DRUG METABOLITE; JATRORRHIZINE 3 O BETA DEXTRO GLUCURONIDE; JATRORRHIZINE 3 O SULFATE; THALIFENDINE; THALIFENDINE 10 O BETA DEXTRO GLUCURONIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG ISOLATION; DRUG STRUCTURE; DRUG TRANSFORMATION; DRUG URINE LEVEL; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ADULT; ANIMALS; BERBERINE; HUMANS; MALE; RATS; RATS, WISTAR; SPECIES SPECIFICITY; STEREOISOMERISM; YOUNG ADULT;

RATTUS;

EID: 54349118402     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.108.021659     Document Type: Article

References (35)

1. Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y, and Issandou M (2006) An additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47:1281-1288.
2. Cicero AF, Rovati LC, and Setnikar I (2007) Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents: a single-blind clinical investigation. Arzneimittelforschung 57:26-30.
3. Doggrell SA (2005) Berberine - a novel approach to cholesterol lowering. Expert Opin Investig Drugs 14:683-685.
4. Hayashi K, Minoda K, Nagaoka Y, Hayashi T, and Uesato S (2007) Antiviral activity of berberine and related compounds against human cytomegalovirus. Bioorg Med Chem Lett 17:1562-1564.
5. Inoue K, Kulsum U, Chowdhury SA, Fujisawa S, Ishihara M, Yokoe I, and Sakagami H (2005) Tumor-specific cytotoxicity and apoptosis-inducing activity of berberines. Anticancer Res 25:4053-4059.
6. Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, et al. (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344-1351.
7. Kulkarni SK and Dhir A (2007) Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 569:77-83.
8. Kuo CL, Chi CW, and Liu TY (2004) The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203:127-137.
9. Lanvers-Kaminsky C, Nolting DM, Köster J, Schröder A, Sandkötter J, and Boos J (2006) In-vitro toxicity of Ukrain against human Ewing tumor cell lines. Anticancer Drugs 17:1025-1030.
10. Lau CW, Yao XQ, Chen ZY, Ko WH, and Huang Y (2001) Cardiovascular actions of berberine. Cardiovasc Drug Rev 19:234-244.
11. Lee CH, Chen JC, Hsiang CY, Wu SL, Wu HC, and Ho TY (2007) Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells. Pharmacol Res 56:193-201.
12. Lin CC, Kao ST, Chen GW, Ho HC, and Chung JG (2006) Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3. Anticancer Res 26:227-242.
13. Lin JP, Yang JS, Chang NW, Chiu TH, Su CC, Lu KW, Ho YT, Yeh CC, Mei-Dueyang, Lin HJ, et al. (2007) GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 27:3379-3386.
14. Ni YX (1988) Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research. Zhong Xi Yi Jie He Za Zhi 8:711-713, 707.
15. Niu F, Xie G, Cu IZ, Chen F, and Tu PF (2006) Chemical constituents from roots of Semiaquilegia adoxoides. J Chin Pharm Sci 15:251-254.
16. Pan GY, Huang ZJ, Wang GJ, Fawcett JP, Liu XD, Zhao XC, Sun JG, and Xie YY (2003) The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 69:632-636.
17. Pan JF, Yu C, Zhu DY, Zhang H, Zeng JF, Jiang SH, and Ren JY (2002) Identification of three sulfate-conjugate metabolites of berberine chloride in health volunteers' urine after oral administration. Acta Pharmacol Sin 21:77-82.
18. Piyanuch R, Sukhthankar M, Wandee G, and Baek SJ (2007) Berberine, a natural isoquinoline alkaloid, induces NAG-1 and ATF3 expression in human colorectal cancer cells. Cancer Lett 258:230-240.
19. Sack RB and Froehlich JL (1982) Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immun 35:471-475.
20. Serafim TL, Oliveira PJ, Sardao VA, Perkins E, Parke D, and Holy J (2008) Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother Pharmacol 61:1007-1018.
21. Shen M-P, Sun Q, and Wang H (1993) Studies on the intravenous pharmacokinetics and oral absorption of berberine HCl in beagle dogs. Chin Pharmacol Bull 9:64-67.
22. Taylor CE and Greenough WB 3rd (1989) Control of diarrheal diseases. Annu Rev Public Health 10:221-244.
23. Turner N, Li JY, Gosby A, To SW, Cheng Z, Miyoshi H, Taketo MM, Cooney GJ, Kraegen EW, James DE, et al. (2008) Berberine, and its more biologically available derivative dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57:1414-1418.
24. Wang YX, Yao XJ, and Tan YH (1994) Effects of berberine on delayed after depolarizations in ventricular muscles in vitro and in vivo. J Cardiovasc Pharmacol 23:716-722.
25. Yan D, Jin C, Xiao XH, and Dong XP (2008) Antimicrobial properties of berberines alkaloids in Coptis chinensis Franch by microcalorimetry. J Biochem Biophys Methods 70:845-849.
26. Yin J, Gao Z, Liu D, Liu Z, and Ye J (2008) Berberine improves glucose metabolism through induction of glycolysis. Am J Physiol Endocrinol Metab 294:E148-E156.
27. Yin J, Hu R, Chen M, Tang J, Li F, Yang Y, and Chen J (2002) Effects of berberine on glucose metabolism in vitro. Metabolism 51:1439-1443.
28. Yu FS, Yang JS, Lin HJ, Yu CS, Tan TW, Lin YT, Lin CC, Lu HF, and Chung JG (2007) Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo 21:407-412.
29. Yu S, Zhang H, PanJun F, Hong Y, Ren J, Zhu D, and Xu X (2000) Determination and preliminary studies of metabolism of berberine in human urine after oral administration. Chin J Clin Pharmacol 16:36-39.
30. Zeng XH, Zeng XJ, and Li YY (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92:173-176.
31. Zeng X and Zeng X (1999) Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomed Chromatogr 13:442-444.
32. Zhang BJ, Xu D, Guo Y, Ping J, Chen LB, and Wang H (2008) Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin Exp Pharmacol Physiol 35:303-309.
33. Zhou L, Yang Y, Wang X, Liu S, Shang W, Yuan G, Li F, Tang J, Chen M, and Chen J (2007) Berberine stimulates glucose transport through a mechanism distinct from insulin. Metabolism 56:405-412.
34. Zhu M, Han F, Chen H, Peng Z, and Chen Y (2007) Identification of palmatine and its metabolites in rat urine by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 21:2019-2022.
35. Zuo F, Nakamura N, Akao T, and Hattori M (2006) Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ ion trap mass spectrometry. Drug Metab Dispos 34:2064-2072.